Antiseizure medication use in self‐limited epilepsies of childhood: A scoping review by the ILAE Pediatric Medical Therapies Task Force
Epilepsia · 16.11.2026
DOI: 10.1002/epi.70559 ↗Kurz gefasst
Scoping Review in der Zeitschrift Epilepsia, online erschienen am 16.11.2026. Verfasst von Ana Carolina Coan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Child Neurology Service, Department of Neurology, University of Campinas, Campinas, São Paulo, Brazil. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Self‐limited focal epilepsies (SeLFEs) of childhood, including self‐limited epilepsy with centrotemporal spikes (SeLECTS), self‐limited epilepsy with autonomic seizures (SeLEAS), childhood occipital visual epilepsy (COVE), and photosensitive occipital lobe epilepsy (POLE), are common pediatric epilepsy syndromes with heterogeneous clinical management. We performed a scoping review to synthesize evidence regarding the use, effectiveness, safety, and discontinuation of antiseizure medications (ASMs) in children with SeLFEs.
Methods
Nine databases were searched from inception to January 2026. Eligible studies included original research reporting ASM‐related outcomes in children with SeLFEs. PRISMA‐ScR (Preferred Reporting Items of Systematic Reviews and Meta‐Analyses, extension for scoping reviews) guidance was followed.
Results
Sixty‐two studies met eligibility criteria, including 11 randomized controlled trials (RCTs). Most studies evaluated SeLECTS (6171 participants), whereas substantially fewer investigated SeLEAS ( n = 348), COVE ( n = 91), or POLE ( n = 26). Evidence was highly heterogeneous and consisted predominantly of retrospective observational studies. In SeLECTS, reported 12‐month seizure freedom rates after ASM treatment were approximately 72% across studies, although estimates varied considerably. Evidence for SeLEAS, COVE, and POLE was limited and derived mainly from small retrospective cohorts with heterogeneous methodologies and outcome definitions. Failure of first‐line ASM therapy occurred in approximately 30% of patients. Adverse events were reported in approximately 22% of treated children and infrequently led to treatment discontinuation. RCTs generally reported similar seizure outcomes across multiple ASMs, although many trials were limited by small sample sizes and open‐label designs. Significance Current evidence suggests that children with SeLFEs often achieve seizure control with ASM treatment and that adverse effects are generally manageable. However, the overall certainty of evidence remains limited because of methodological heterogeneity, predominance of retrospective studies, and limited randomized data. Important evidence gaps remain regarding the need for ASM treatment, optimal treatment duration, and timing of medication withdrawal.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Child Neurology Service, Department of Neurology, University of Campinas, Campinas, São Paulo, Brazil.
- Alberta Children's Research Institute and Hodgekiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
- Department of Paediatrics, University of Colombo, Colombo, Sri Lanka.
- Divisions of Child and Adolescent Neurology and Epilepsy, Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
- Research Department of Epilepsy, University College London, Queen Square Institute of Neurology, London, UK.
- Chalfont Centre for Epilepsy, Buckinghamshire, UK.
ORCID-Profile: Ana Carolina Coan, Julia Jacobs, Jithangi Wanigasinghe, Elaine Wirrell, Simona Balestrini, Ingrid E Scheffer, Stephane Auvin, Kelly G Knupp, Rima Nabbout, Nathalie Jette, Francesco Brigo, Kette Valente
Zitieren
APA
Coan, A. C., Jacobs, J., Wanigasinghe, J., Wirrell, E., Balestrini, S., Scheffer, I. E., Auvin, S., Knupp, K. G., Nabbout, R., Jette, N., Brigo, F., & Valente, K. (2026). Antiseizure medication use in self‐limited epilepsies of childhood: A scoping review by the ILAE Pediatric Medical Therapies Task Force. Epilepsia. https://doi.org/10.1002/epi.70559
Vancouver
Coan AC, Jacobs J, Wanigasinghe J, Wirrell E, Balestrini S, Scheffer IE, et al. Antiseizure medication use in self‐limited epilepsies of childhood: A scoping review by the ILAE Pediatric Medical Therapies Task Force. Epilepsia. 2026. doi:10.1002/epi.70559
BibTeX
@article{Coan2026,
author = {Coan, Ana Carolina and Jacobs, Julia and Wanigasinghe, Jithangi and Wirrell, Elaine and Balestrini, Simona and Scheffer, Ingrid E and Auvin, Stephane and Knupp, Kelly G and Nabbout, Rima and Jette, Nathalie and Brigo, Francesco and Valente, Kette},
title = {Antiseizure medication use in self‐limited epilepsies of childhood: A scoping review by the ILAE Pediatric Medical Therapies Task Force},
journal = {Epilepsia},
year = {2026},
doi = {10.1002/epi.70559}
}
EUVIMED